GVHD
GVHD
Advertisement
Karen Pischke, BSN, RNGVHD | May 8, 2025
A nursing team from Tufts Medical Center discusses their case presentation on the use of Reiki in a patient with cGVHD.
View More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Best Practices | May 8, 2025
Learn what oncology nurses should know about how it works, the FDA-approved products, legal considerations, and more.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | May 8, 2025
Oncology nurses must be prepared to use non-stigmatizing, culturally sensitive communication about cannabis to manage GVHD.
Cecilia BrownGVHD | May 7, 2025
The analysis shows that certain social factors may affect GVHD risk and severity.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 11, 2025
Oncology nurses need to monitor these 2 distinct but interconnected complications after allogeneic stem cell transplantation.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 11, 2025
Learn how machine learning models may be able to assist interdisciplinary teams with tailoring GVHD management.
Laura LitwinGVHD | March 27, 2025
The study revealed domains not represented in existing GVHD- or dermatologic-specific patient-reported outcome measures.
Laura LitwinGVHD | March 21, 2025
The condition is an "underdiagnosed gynecologic comorbidity" that often co-occurs with multiorgan chronic GVHD.
Laura LitwinGVHD | March 12, 2025
Previous research showed a potential connection between obesity and moderate to severe GVHD post-allogeneic SCT.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 11, 2025
Oncology nurses need to be equipped to dispel common myths about smoking.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 11, 2025
Learn how oncology nurses can offer education and smoking cessation resources to help patients reduce their risk.
Stephen R. SpellmanConferences | March 6, 2025
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | February 26, 2025
Recent research highlights the need for proactive interventions by oncology nurses.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | February 26, 2025
If patients who smoke understand the pathophysiology, they may be more open to difficult conversations about cessation.
Laura LitwinConferences | March 7, 2025
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Laura LitwinGVHD | February 14, 2025
The study evaluated the safety and efficacy of ruxolitinib for treating chronic graft-versus-host disease after allo-HSCT.
Cecilia BrownGVHD | February 11, 2025
Partially hydrolyzed guar gum, a soluble dietary fiber obtained from guar beans, was evaluated due to its butyrate content.
Cecilia BrownGVHD | February 11, 2025
The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback.
Laura LitwinGVHD | February 7, 2025
Patients with cGVHD appreciate the opportunity to connect with other individuals also navigating a cGVHD diagnosis.
Laura LitwinGVHD | January 29, 2025
Access to a multidisciplinary GVHD clinic with telehealth abilities improved care for patients with acute and chronic GVHD.
Advertisement
Advertisement